☆ 4.6 Letter

Fludarabine, Bortezomib, Myocet (R) and rituximab chemotherapy in relapsed and refractory mantle cell lymphoma

BRITISH JOURNAL OF HAEMATOLOGY (2010)

Journal

BRITISH JOURNAL OF HAEMATOLOGY

Volume 148, Issue 5, Pages 810-812

Publisher

WILEY-BLACKWELL PUBLISHING, INC

DOI: 10.1111/j.1365-2141.2009.07998.x

Keywords

bortezomib; fludarabine; liposomal doxorubicin; mantle cell lymphoma; rituximab

Categories

Hematology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.